eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 04/07/2011
PIL MYFORTIC 180mg gastro-resistant tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 05/04/2011 and displayed until 04/07/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 18/04/2008 and displayed until 05/04/2011
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 14/01/2008 and displayed until 18/04/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/09/2006 and displayed until 14/01/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to side-effects
Updated on 02/09/2004 and displayed until 14/09/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  mycophenolic acid as mycophenolate sodium